Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 88,674 shares, a growth of 2,437.2% from the July 30th total of 3,495 shares. Based on an average trading volume of 307,856 shares, the days-to-cover ratio is currently 0.3 days. Approximately 3.9% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Arcadia Biosciences has a consensus rating of “Sell”.

Arcadia Biosciences Trading Up 2.0%

RKDA stock traded up $0.01 during trading hours on Tuesday, hitting $0.49. 56,755 shares of the stock traded hands, compared to its average volume of 238,036. The stock has a 50-day simple moving average of $0.65 and a 200 day simple moving average of $1.12. The company has a market cap of $1.18 million, a P/E ratio of -0.11 and a beta of 0.56. Arcadia Biosciences has a one year low of $0.38 and a one year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%.The business had revenue of $1.44 million during the quarter, compared to the consensus estimate of $1.90 million.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.